Negócios · 30/06/20051 min de leitura
"Guidance for Industry: Discontinuation of Donor Deferral Related to Recent Fever with Headache as a Symptom of West Nile Virus Infection"; Withdrawal of Guidance
Tradução automática local · Idioma original da fonte
Resumo
The Food and Drug Administration (FDA) is announcing the withdrawal of a guidance entitled "Guidance for Industry: Discontinuation of Donor Deferral Related to Recent Fever with Headache as a Symptom of West Nile Virus Infection" (May 2005 guidance) that was issued on May 6, 2005. A guidance entitled " Guidance for Industry: Assessing Donor Suitability and Blood and Blood Product Safety in Cases of Known or Suspected West Nile Virus Infection," dated June 2005, is being announced elsewhere in this issue of the Federal Register, and supersedes the May 2003 guidance entitled "Guidance for Industry: Revised Recommendations for the Assessment of Donor Suitability and Blood and Blood Product Safety in Cases of Known or Suspected West Nile Virus Infection" (May 2003 guidance) (68 FR 25897).